AstraZeneca is expanding into rare endocrinology after acquiring French biotech, Amolyt Pharma
Boehringer secures an opportunity to boost its schizophrenia portfolio
Boehringer is taking steps to cut patient costs for all its inhaler products
Bristol Myers Squibb's Opdivo received FDA nod for treating bladder cancer in combination with chemotherapy
Eli Lilly's eczema medicine cleared skin and provided itch relief in people of color
Eli Lilly partners with Amazon pharmacy for home delivery of its weight loss, diabetes and migraine drugs
Merck & Gilead's HIV drug combinations maintained a high rate of viral suppression in patients
Novo's Nordisk's new oral obesity drug may show superiority over its injectable, Wegovy
Novo Nordisk's Wegovy just added a new cardiovascular FDA approval to its label
J&J's lung cancer drug, Rybrevant, receives FDA approval as a first-line treatment alongside chemotherapies
Biden requests funding for women's health research for conditions such as Alzheimer's disease, menopause and endometriosis
FDA approves the first drug for fatty liver disease (MASH)
Eli Lilly flags raises concerns over fake GLP-1 drugs that falsely claim to be real, FDA approved medicines
Everlywell crushes "stool stigma" to increase at home colon cancer screening rates
Gilead launches patient hub to share stories of patients living metastatic breast cancer
American Cancer society partners with Colorectal Cancer Alliance to launch a campaign aimed at boosting colorectal cancer screen for 45 years old and above
%402x.svg){kind=icon}
.png)
%402x.svg){kind=icon}
